Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuhiro Tanaka

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Scientific Reports|March 2, 2018
Genome-wide analysis revealed that DZNep reduces tubulointerstitial fibrosis via down-regulation of pro-fibrotic genesImari Mimura, Yosuke Hirakawa, Yasuharu Kanki, et al.
Journal of the American Society of Nephrology : JASN|March 23, 2004
Modulation of interferon-induced genes by lipoxin analogue in anti-glomerular basement membrane nephritisTakamoto Ohse, Tatsuru Ota, Niamh Kieran, et al.
Clinical and Experimental Nephrology|December 27, 2022
Usefulness of gallium-67 scintigraphy for evaluating the histopathological activity in interstitial nephritisMimiko Matsumura, Akira Okada, Hiroaki Yokoyama, et al.
Scientific Reports|December 8, 2025
Management status of patients with chronic kidney disease across medical specialties in Japan: a real-world data analysisShoichi Maruyama, Tetsuhiro Tanaka, Hirobumi Igawa, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in ratsMakiko Matsumoto, Yuichi Makino, Tetsuhiro Tanaka, et al.
Clinical and Experimental Nephrology|January 24, 2019
Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in JapanTetsuhiro Tanaka, Masaomi Nangaku, Enyu Imai, et al.
Scientific Reports|April 29, 2021
β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic miceTakaaki Higashihara, Hiroshi Nishi, Koji Takemura, et al.
Clinical and Experimental Nephrology|September 6, 2018
Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in JapanTetsuhiro Tanaka, Masaomi Nangaku, Enyu Imai, et al.
Scientific Reports|March 2, 2024
Population characteristics and diagnosis rate of chronic kidney disease by eGFR and proteinuria in Japanese clinical practice: an observational database studyTetsuhiro Tanaka, Shoichi Maruyama, Noriharu Chishima, et al.
Clinical Kidney Journal|August 22, 2024
Cardiovascular, renal and mortality risk by the KDIGO heatmap in JapanShoichi Maruyama, Tetsuhiro Tanaka, Hiroki Akiyama, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Scientific Reports|March 2, 2018
Genome-wide analysis revealed that DZNep reduces tubulointerstitial fibrosis via down-regulation of pro-fibrotic genesImari Mimura, Yosuke Hirakawa, Yasuharu Kanki, et al.
Journal of the American Society of Nephrology : JASN|March 23, 2004
Modulation of interferon-induced genes by lipoxin analogue in anti-glomerular basement membrane nephritisTakamoto Ohse, Tatsuru Ota, Niamh Kieran, et al.
Clinical and Experimental Nephrology|December 27, 2022
Usefulness of gallium-67 scintigraphy for evaluating the histopathological activity in interstitial nephritisMimiko Matsumura, Akira Okada, Hiroaki Yokoyama, et al.
Scientific Reports|December 8, 2025
Management status of patients with chronic kidney disease across medical specialties in Japan: a real-world data analysisShoichi Maruyama, Tetsuhiro Tanaka, Hirobumi Igawa, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in ratsMakiko Matsumoto, Yuichi Makino, Tetsuhiro Tanaka, et al.
Clinical and Experimental Nephrology|January 24, 2019
Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in JapanTetsuhiro Tanaka, Masaomi Nangaku, Enyu Imai, et al.
Scientific Reports|April 29, 2021
β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic miceTakaaki Higashihara, Hiroshi Nishi, Koji Takemura, et al.
Clinical and Experimental Nephrology|September 6, 2018
Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in JapanTetsuhiro Tanaka, Masaomi Nangaku, Enyu Imai, et al.
Scientific Reports|March 2, 2024
Population characteristics and diagnosis rate of chronic kidney disease by eGFR and proteinuria in Japanese clinical practice: an observational database studyTetsuhiro Tanaka, Shoichi Maruyama, Noriharu Chishima, et al.
Clinical Kidney Journal|August 22, 2024
Cardiovascular, renal and mortality risk by the KDIGO heatmap in JapanShoichi Maruyama, Tetsuhiro Tanaka, Hiroki Akiyama, et al.
Pageof 15